Zinnia Parra-Guillen

13PUBLICATIONS
35CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsSystems physiologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 18, 2025
Leveraging in vitro Tumor Cell Killing and Cytokine Release to Predict Cytokine Release Syndrome Associated with CD3 T-cell Bispecifics in Oncology: a Retrospective Analysis.

Apolline Lefèvre, Zinnia P Parra-Guillen, Iñaki F Trocóniz

|Oct 10, 2025
A First-in-Class mAb (BI-1607) Targeting FcγRIIB: Preclinical Data and First-in-Human Studies in Patients with HER2-Positive Advanced Solid Tumors.

Javier Cortés, Araceli Priego, Elena Garralda

|Aug 01, 2025
Role of Antidrug Antibodies in Oncolytic Viral Therapy: A Dynamic Modelling Approach in Cancer Patients Treated with V937 Alone or in Combination.

Zinnia P Parra-Guillen, Iñaki F Trocóniz, Tomoko Freshwater

|Jan 25, 2025
Development and Application of Physiologically-Based Pharmacokinetic Model to Predict Systemic and Organ Exposure of Colorectal Cancer Drugs.

Sara Peribañez-Dominguez, Zinnia Parra-Guillen, Iñaki F Troconiz

|Jan 08, 2025
Pharmacodynamic Model of the Hemodynamic Effects of Propofol and Remifentanil and Their Interaction with Noxious Stimulation.

Maite Garraza-Obaldia, Sebastian Jaramillo, Zinnia P Parra-Guillen

|Jul 22, 2024
Disentangling Anti-Tumor Response of Immunotherapy Combinations: A Physiologically Based Framework for V937 Oncolytic Virus and Pembrolizumab.

Aymara Sancho-Araiz, Zinnia P Parra-Guillen, Iñaki F Troconiz

Pageof 3

Frequent Collaborators

9 joint publications

Iñaki F Trocóniz

2 joint publications

Eduardo Asín-Prieto

2 joint publications

Diego Vera-Yunca

2 joint publications

Aymara Sancho-Araiz